Induction of
arthritis in rats with Freund's complete adjuvant was accompanied by a distinctive alteration of
concanavalin A (Con-A) reactivity in their
serum proteins in which the concentrations of selected Con-A reactive
proteins were significantly higher when compared to healthy rats. To assess if the observed increase in Con-A reactivity of specific
serum proteins reflects an increase in
carbohydrate moieties in these
proteins in addition to an increase in their
protein concentrations, a
heme binding serum
glycoprotein,
hemopexin, also an
acute phase reactant, was selected as a marker
protein.
Hemopexin was purified to apparent homogeneity from pools of serum samples derived from rats with yeast induced
inflammation, a monospecific polyclonal antibody was prepared and was used for immunoblot analysis. It was noted that the concentration of
hemopexin increased in rats with adjuvant induced
arthritis; however, its concentration fell to normal levels after administration with a newly synthesized
drug,
bindarit, (2-[(1-benzyl-indazol-3-yl)methoxy]-2-methyl
propionic acid, C19H20N2O3.
Hemopexin was micropurified individually from healthy rats, adjuvant induced arthritic rats, and adjuvant arthritic rats treated with
bindarit, cleaved with a Glu-C
endopeptidase, Staphylococcus aureus
protease V8, and the resultant
peptide fragments resolved by SDS-PAGE and examined by
silver staining,
Coomassie blue staining, and
lectin blots using Con-A. It was subsequently noted that
hemopexin isolated from adjuvant induced arthritic rats showed a significant increase in Con-A reactivity in selected
peptide fragments and that such an increase in glycosylation could be reversed to a pattern similar to healthy rats following treatment with
bindarit.(ABSTRACT TRUNCATED AT 250 WORDS)